TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease

Basit Öğe Kaydı
dc.authoridADALI, GUPSE/0000-0003-2157-0304
dc.authoridYılmaz, Funda/0000-0003-1837-6498
dc.authoridCosar, Arif Mansur/0000-0002-4472-2895
dc.authoridYilmaz, Yusuf/0000-0003-4518-5283
dc.authoridsahin, mustafa/0000-0002-4718-0083
dc.authoridCengiz Seval, Guldane/0000-0001-9433-2054
dc.authoridSertesen Camoz, Elif/0000-0002-1991-6620
dc.authorwosidCoşar, Arif/AAL-2119-2020
dc.authorwosidADALI, GUPSE/C-5726-2017
dc.authorwosidYılmaz, Funda/O-9646-2018
dc.authorwosidCosar, Arif Mansur/AAL-1608-2020
dc.authorwosidYilmaz, Yusuf/K-6651-2012
dc.authorwosidSertesen, Elif/KJM-8461-2024
dc.authorwosidsahin, mustafa/AAH-3394-2019
dc.contributor.authorYilmaz, Yusuf
dc.contributor.authorZeybel, Mujdat
dc.contributor.authorAdali, Gupse
dc.contributor.authorCosar, Arif Mansur
dc.contributor.authorSertesen, Elif
dc.contributor.authorGokcan, Hale
dc.contributor.authorBahcecioglu, Halil Ibrahim
dc.date.accessioned2024-08-04T21:01:17Z
dc.date.available2024-08-04T21:01:17Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractNonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is significantly associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. NAFLD has become the most prevalent chronic liver disease in Western countries, and the proportion of NAFLD-related cirrhosis among patients on liver transplantation waiting lists has increased. In light of the accumulated data about NAFLD, and to provide a common approach with multi-disciplines dealing with the subject, it has become necessary to create new guidance for diagnosing and treating NAFLD. This guidance was prepared following an interdisciplinary study under the leadership of the Turkish Association for the Study of the Liver (TASL), Fatty Liver Special Interest Group. This new TASL Guidance is a practical application guide on NAFLD and was prepared to standardize the clinical approach to diagnosing and treating NAFLD patients. This guidance reflects many advances in the field of NAFLD. The proposals in this guidance are meant to aid decision-making in clinical practice. The guidance is primarily intended for gastroenterology, endocrinology, metabolism diseases, cardiology, internal medicine, pediatric specialists, and family medicine specialists.en_US
dc.identifier.doi10.14744/hf.2023.2023.0011
dc.identifier.endpage32en_US
dc.identifier.issn1307-5888
dc.identifier.issn2757-7392
dc.identifier.pmid37920782en_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.14744/hf.2023.2023.0011
dc.identifier.urihttps://hdl.handle.net/11616/104257
dc.identifier.volume4en_US
dc.identifier.wosWOS:001042091100001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofHepatology Forumen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNonalcoholic fatty liver diseaseen_US
dc.subjectnonalcoholic steatohepatitisen_US
dc.subjecthepatosteatosisen_US
dc.subjectnoninvasive diagnostic testsen_US
dc.subjectchronic hepatitisen_US
dc.subjectcirrhosisen_US
dc.titleTASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Diseaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu